Thanks rgshredder. Disappointing news. I am still stumped on the short thesis unless it is just a daily volume % and they are not holding them overnight. There has been a clear resistance level at the 50 dma so maybe this is the game they have been playing while we wait for Q3 results. Lots of ups and downs to make money. I am certainly going to be hedged going into November.
On a brighter note, here are some Yescarta results from the phase 1 leukemia study. 84% complete response for patients who have tried multiple treatments!
News 
Market Data 
Discover 
